Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 73

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 73
---
Repare advised
Leerink Partners that it did not have a standalone business plan and its plan in the absence of a sale or merger of the company was to pursue a dissolution of Repare. Accordingly, Leerink Partners concluded, in the exercise of its professional
judgment, that traditional valuation methodologies typically used for purposes

41

of valuing a business as a going concern were not applicable to Repare. Repare management furnished to Leerink Partners the Dissolution Analysis prepared by management as described in more detail
under “— Repare Management Dissolution Analysis” and directed Leerink Partners to rely upon the Dissolution Analysis for purposes of its analysis and opinion. The Dissolution Analysis assumed an initial distribution of cash
to holders of Shares as of December 31, 2025, of approximately $55 million, or $1.26 per Share, and a second distribution of cash to holders of Shares as of March 31, 2026, of approximately $18 million, or an estimated present
value of approximately $0.41 per Share (as described below), and a final distribution of cash to holders of Shares as of December 31, 2027, of approximately $2.5 million, or an estimated present value of approximately $0.05 per Share (as
described below). Together, the initial distribution, second distribution and the final distribution are referred to in this section as the “Dissolution Payments.”

Leerink Partners compared the assumed value of the Cash Consideration of $1.82 per Common Share to the present value of the Dissolution
Payments as of December 31, 2025 (the assumed date of approval by shareholders of Repare of a dissolution of Repare). For purposes of comparison, Leerink Partners discounted the Cash Consideration from January 31, 2026 (the assumed closing
date of the Transaction), and further discounted the Dissolution Payments, in each case, to November 14, 2025. Leerink Partners calculated the December 31, 2025 present value of the Dissolution Payments by discounting the March 31, 2026
second distribution payment to December 31, 2025 and the December 31, 2027 final distribution payment to December 31, 2025 using a discount rate equivalent to ICE BofA US High Yield Index Effective Yield of 6.82% as of November 13,
2025, and adding these discounted amounts to the amount of the initial distribution payment. Leerink